A. Proudfoot
Immunology · 2001–2014
A researcher in the Science corpus: 6 papers; trusts 5 researchers and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Immunology — 84 citations into it; #794 of 2,160 by trust here, #1,064 by citations
- Oncology — 58 citations into it; #584 of 1,698 by trust here, #837 by citations
- Molecular Biology — 18 citations into it
Whom A. Proudfoot trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts A. Proudfoot overall
Papers from A. Proudfoot's perspective
Ordered by how strongly the researchers A. Proudfoot trusts endorse each paper. Same corpus, a different order for every researcher.
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy (Nature Medicine)
- Requirement of the Chemokine Receptor CXCR3 for Acute Allograft Rejection (Journal of Experimental Medicine)
- Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. (Brain : a journal of neurology)
- Involvement of chemokine receptors in breast cancer metastasis (Nature)
- The immune response in atherosclerosis: a double-edged sword (Nature reviews. Immunology)
- Cytokines in atherosclerosis: pathogenic and regulatory pathways. (Physiological Reviews)
- High-Mobility Group Box-1 in Ischemia-Reperfusion Injury of the Heart (Circulation)
- Understanding dendritic cell and T‐lymphocyte traffic through the analysis of chemokine receptor expression (Immunological Reviews)
- Endogenous HMGB1 regulates autophagy (Journal of Cell Biology)
- Toll-like receptor 9–dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE (Nature Immunology)
Their papers
- Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines (2003) — 862 citations
- International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors (2014) — 736 citations
- HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4 (2012) — 644 citations
- Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6Chi and Ly6Clo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice (2008) — 710 citations
- Chemokine receptors: multifaceted therapeutic targets (2002) — 784 citations
- RANTES Deposition by Platelets Triggers Monocyte Arrest on Inflamed and Atherosclerotic Endothelium (2001) — 636 citations